Metabolomics in drug target discovery

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 76, Issue , 2011, Pages 235-246

  Rabinowitz, J D ^a   Purdy, J G ^a   Vastag, L ^a   Shenk, T ^a   Koyuncu, E ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYGLUTARIC ACID; 2 OXOGLUTARIC ACID; ACETYL COENZYME A; GLUCOSE; GLUTAMINE; N ACETYLASPARTIC ACID; SIALIDASE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

ARTICLE; CARBON METABOLISM; CONCENTRATION (PARAMETERS); CYTOMEGALOVIRUS INFECTION; DRUG DEVELOPMENT; ENZYME ACTIVITY; FIBROBLAST; GAS CHROMATOGRAPHY; HERPES SIMPLEX VIRUS 1; HUMAN; INFLUENZA A; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NITROGEN AVAILABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UPREGULATION; VIRUS INFECTION; VIRUS REPLICATION; CITRIC ACID CYCLE; DRUG TARGETING; HUMAN CYTOMEGALOVIRUS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; ASPARTIC ACID; DRUG DISCOVERY; HUMANS; ISOTOPE LABELING; METABOLOMICS;

EID: 84867434804     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2011.76.010694     Document Type: Article

References (69)

1. Bajad SU, Lu W, Kimball EH, Yuan J, Peterson C, Rabinowitz JD. 2006. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography- tandem mass spectrometry. J Chromatogr A 1125: 76-8
2. Baran R, Kochi H, Saito N, Suematsu M, Soga T, Nishioka T, Robert M, Tomita M. 2006. MathDAMP: A package for differential analysis of metabolite profiles. BMC Bioinformatics 7: 53
3. Beger RD, Hansen DK, Schnackenberg LK, Cross BM, Fatollahi JJ, Lagunero FT, Sarnyai Z, Boros LG. 2009. Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-D-glucose tracer in mice. Metabolomics 5: 336-34
4. Brauer MJ, Yuan J, Bennett BD, Lu W, Kimball E, Botstein D, Rabinowitz JD. 2006. Conservation of the metabolomic response to starvation across two divergent microbes. Proc Natl Acad Sci 103: 19302-1930
5. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ. 2002. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1HNMR-based metabonomics. Nat Med 8: 1439-144
6. Buescher JM, Czernik D, Ewald JC, Sauer U, Zamboni N. 2009. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal Chem 81: 2135-214
7. Buescher JM, Moco S, Sauer U, Zamboni N. 2010. Ultrahigh performance liquid chromatography-tandem mass spectrometry method for fast and robust quantification of anionic and aromatic metabolites. Anal Chem 82: 4403-441
8. Castro-Perez J, Previs SF, McLaren DG, Shah V, Herath K, Bhat G, Johns DG, Wang SP, Mitnaul L, Jensen K, et al. 2011. In vivo D2O labeling to quantify static and dynamic changes in cholesterol and cholesterol esters by high resolution LC/ MS. J Lipid Res 52: 159-16
9. Chambers JW, Maguire TG, Alwine JC. 2010. Glutamine metabolism is essential for human cytomegalovirus infection. J Virol 84: 1867-187
10. Clasquin MF, Melamud E, Singer A, Gooding JR, Xu X, Dong A, Cui H, Campagna SR, Savchenko A, Yakunin AF, et al. 2011. Riboneogenesis in yeast. Cell 145: 969-98
11. Clippinger AJ, Maguire TG, Alwine JC. 2011. The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection. J Virol 85: 3930-393
12. Crutchfield CA, LuW, Melamud E, Rabinowitz JD. 2010. Mass spectrometry-based metabolomics of yeast. Methods Enzymol 470: 393-42
13. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-74
14. DeMeritt IB, Milford LE, Yurochko AD. 2004. Activation of the NF-kB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 78: 4498-450
15. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BØ. 2007. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci 104: 1777-178
16. Evers DL, Wang X, Huang ES. 2004. Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect 6: 1084-109
17. Fan TW, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM. 2009. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotoperesolved metabolomics (SIRM). Mol Cancer 8: 4
18. Fiehn O. 2002. Metabolomics-The link between genotypes and phenotypes. Plant Mol Biol 48: 155-17
19. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. 2010. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18: 553-56
20. Hegeman AD, Schulte CF, Cui Q, Lewis IA, Huttlin EL, Eghbalnia H, Harms AC, Ulrich EL, Markley JL, Sussman MR. 2007. Stable isotope assisted assignment of elemental compositions for metabolomics. Anal Chem 79: 6912-692
21. Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S. 2006. Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3: e32
22. Ibarra RU, Edwards JS, Palsson BO. 2002. Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature 420: 186-18
23. Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K. 2010. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 58: 12-18; discussion 20-2
24. Kaddurah-Daouk R. 2006. Metabolic profiling of patients with schizophrenia. PLoS Med 3: e36
25. Katajamaa M, Miettinen J, Oresic M. 2006. MZmine: Toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22: 634-63
26. Katz JE, Dumlao DS, Clarke S, Hau J. 2004. A new technique (COMSPARI) to facilitate the identification of minor compounds in complex mixtures by GC/MS and LC/MS: Tools for the visualization of matched datasets. J Am Soc Mass Spectrom 15: 580-58
27. Kind T, Fiehn O. 2006. Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 7: 23
28. Kind T, Fiehn O. 2007. Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics 8: 10
29. Kudchodkar SB, Yu Y, Maguire TG, Alwine JC. 2004. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J Virol 78: 11030-1103
30. Kudchodkar SB, Yu Y, Maguire TG, Alwine JC. 2006. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes. Proc Natl Acad Sci 103: 14182-1418
31. Kwon YK, Lu W, Melamud E, Khanam N, Bognar A, Rabinowitz JD. 2008. A domino effect in antifolate drug action in Escherichia coli. Nat Chem Biol 4: 602-60
32. Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, et al. 2003. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187: 137-14
33. Liu ST, Sharon-Friling R, Ivanova P, Milne SB, Myers DS, Rabinowitz JD, Brown HA, Shenk T. 2011. Synaptic vesiclelike lipidome of human cytomegalovirus virions reveals a role for SNARE machinery in virion egress. Proc Natl Acad Sci 108: 12869-1287
34. Lu W, Clasquin MF, Melamud E, Amador-Noguez D, Caudy AA, Rabinowitz JD. 2010. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal Chem 82: 3212-322
35. Luo B, Groenke K, Takors R, Wandrey C, Oldiges M. 2007. Simultaneous determination of multiple intracellular metabolites in glycolysis, pentose phosphate pathway and tricarboxylic acid cycle by liquid chromatography-mass spectrometry. J Chromatogr A 1147: 153-16
36. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, et al. 2009. Recurring mutations found by sequencing an acute myeloid leukemia genome. New Engl J Med 361: 1058-106
37. Marrero J, Rhee KY, Schnappinger D, Pethe K, Ehrt S. 2010. Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci 107: 9819-982
38. Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, et al. 2007. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: A cohort analysis. Blood 110: 490-50
39. McArdle J, Schafer XL, Munger J. 2011. Inhibition of calmodulin-dependent kinase kinase blocks human cytomegalovirusinduced glycolytic activation and severely attenuates production of viral progeny. J Virol 85: 705-71
40. Melamud E, Vastag L, Rabinowitz JD. 2010. Metabolomic analysis and visualization engine for LC-MS data. Anal Chem 82: 9818-982
41. Moorman NJ, Cristea IM, Terhune SS, Rout MP, Chait BT, Shenk T. 2008. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe 3: 253-26
42. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. 2006, Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2: e13
43. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26: 1179-118
44. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, et al. 2009. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-32
45. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. 2010. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140: 49-6
46. Nomura DK, Lombardi DP, Chang JW, Niessen S, Ward AM, Long JZ, Hoover HH, Cravatt BF. 2011. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem Biol 18: 846-85
47. Olszewski KL, Mather MW, Morrisey JM, Garcia BA, Vaidya AB, Rabinowitz JD, Llinas M. 2010. Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 466: 774-77
48. Panchal AR, Comte B, Huang H, Kerwin T, Darvish A, des Rosiers C, Brunengraber H, Stanley WC. 2000. Partitioning of pyruvate between oxidation and anaplerosis in swine hearts. Am J Physiol Heart Circ Physiol 279: H2390-H239
49. Panchal AR, Comte B, Huang H, Dudar B, Roth B, Chandler M, Des Rosiers C, Brunengraber H, Stanley WC. 2001. Acute hibernation decreases myocardial pyruvate carboxylation and citrate release. Am J Physiol Heart Circ Physiol 281: H1613-H162
50. Pesek JJ, Matyska MT, Loo JA, Fischer SM, Sana TR. 2009. Analysis of hydrophilic metabolites in physiological fluids by HPLC-MS using a silica hydride-based stationary phase. J Sep Sci 32: 2200-220
51. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE. 2005. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112: 3868-387
52. Sauer U. 2006. Metabolic networks in motion: 13C-based flux analysis. Mol Syst Biol 2: 6
53. Sharon-Friling R, Goodhouse J, Colberg-Poley AM, Shenk T. 2006. Human cytomegalovirus pUL37 × 1 induces the release of endoplasmic reticulum calcium stores. Proc Natl Acad Sci 103: 19117-1912
54. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. 2006. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78: 779-78
55. Spencer CM, Schafer XL, Moorman NJ, Munger J. 2011. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol 85: 5814-582
56. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, et al. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-91
57. Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD. 2011. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog 7: e100212
58. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, et al. 2011. Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-45
59. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, et al. 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting a-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17: 225-23
60. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Xiao MT, Liu LX, et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19: 17-3
61. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, et al. 2009. IDH1 and IDH2 mutations in gliomas. New Engl J Med 360: 765-77
62. Yang D, Previs SF, Fernandez CA, Dugelay S, Soloviev MV, Hazey JW, Agarwal KC, Levine WC, David F, Rinaldo P, et al. 1996. Noninvasive probing of citric acid cycle intermediates in primate liver with phenylacetylglutamine. Am J Physiol 270: E882-E88
63. Yizhak K, Benyamini T, Liebermeister W, Ruppin E, Shlomi T. 2010. Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics 26: i255-i26
64. Yuan J, Rabinowitz JD. 2007. Differentiating metabolites formed from de novo synthesis versus macromolecule decomposition. J Am Chem Soc 129: 9294-929
65. Yuan J, Fowler WU, Kimball E, Lu W, Rabinowitz JD. 2006. Kinetic flux profiling of nitrogen assimilation in Escherichia coli. Nat Chem Biol 2: 529-53
66. Yuan J, Bennett BD, Rabinowitz JD. 2008. Kinetic flux profiling for quantitation of cellular metabolic fluxes. Nat Protoc 3: 1328-134
67. Yuan J, Doucette CD, Fowler WU, Feng XJ, Piazza M, Rabitz HA, Wingreen NS, Rabinowitz JD. 2009. Metabolomicsdriven quantitative analysis of ammonia assimilation in E. coli. Mol Syst Biol 5: 30
68. Yurochko AD. 2008. Human cytomegalovirus modulation of signal transduction. Curr Top Microbiol Immunol 325: 205-22
69. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, et al. 2009. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1a. Science 324: 261-26